Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,174 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

NCT01797445

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Spectrum Medical Group Phoenix, Arizona, United States
  • Kaiser Permanente - Los Angeles Medical Center Los Angeles, California, United States
  • University of Southern California AIDS Clinical Trials Group Los Angeles, California, United States
View all 117 locations
View Trial Details
Completed

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

NCT01818596

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Maricopa Integrated Health System - McDowell Clinic Phoenix, Arizona, United States
  • Pueblo Family Physicians Phoenix, Arizona, United States
  • Health for Life Clinic PLLC Little Rock, Arkansas, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
View all 70 locations
View Trial Details
Completed

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

NCT03036839

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • James J. Peters VA Hospital The Bronx, New York, United States
  • The Liver Institute at Methodist Dallas Medical Center Dallas, Texas, United States
View all 21 locations
View Trial Details
Completed

Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis

NCT02994056

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Tampa General Medical Group Tampa, Florida, United States
  • Northwestern Memorial Hospital; Clinical Research Unit Chicago, Illinois, United States
  • Digestive Disease Associates, PA Catonsville, Maryland, United States
  • Southern Therapy and Advanced Research LLC Jackson, Mississippi, United States
View Trial Details
Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection

NCT02249182

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • San Francisco, California, United States
  • Aurora, Colorado, United States
View all 31 locations
View Trial Details
Completed

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals

NCT02786758

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Melbourne Sexual Health Centre Carlton, Victoria, Australia
  • Northside Clinic Fitzroy North, Victoria, Australia
  • Alfred Health, The Alfred Hospital Melbourne, Victoria, Australia
  • Melbourne Health, Royal Melbourne Hospital Parkville, Victoria, Australia
View Trial Details
Completed

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

NCT03092375

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Health Research Institute Washington D.C., District of Columbia, United States
View all 31 locations
View Trial Details

Related conditions